News Archive
Masonic Cancer Center Articles
Masonic Cancer Center Clinical Trials
As one of only 51 NCI-Designated comprehensive cancer centers throughout the United States, the Masonic Cancer Center, University Minnesota’s mission is to serve the people of Minnesota and to put our energy and skills towards ending the…
NCI-designated cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track
The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention.
Today, doctors and scientists across America at National Cancer Institute (NCI)-…
Clinical Trials Day 2021
Happy Clinical Trials Day! Today is a day to celebrate those who conduct and participate in clinical research. Hear from the MNCCTN HUB, partners, and site staff about why we love working in research and how research creates impact.
Dr. Jeffrey Miller Awarded $9M NIH/NCI P01 Program Project Grant to Develop Off-The-Shelf NK Cells
MINNEAPOLIS/ST. PAUL — Jeffrey Miller, MD, Deputy Director of the Masonic Cancer Center, and his research team have been awarded a $9M National Institutes of Health (NIH) P01 Program Project Grant grant from the National Cancer Institute (…
Masonic Cancer Center Celebrates 30th Anniversary
MINNEAPOLIS/ST.
FDA makes announcement to proceed with a ban on menthol cigarettes and flavored cigars
Yesterday, the U.S. Food and Drug Administration took steps to ban the sale of menthol-flavored cigarettes and all flavored cigars within the next year, according to an agency announcement.
Call for Grant Applications for the Kure It Cancer Research Fellowship Grant
Kure It is accepting grant applications from comprehensive cancer centers. Kure It Cancer Research was established in 2007 with the goal of becoming the leader in granting funds to cancer researchers conducting innovative research projects…
Institute researchers find new cancer driver in cells
AUSTIN, Minn – April 15, 2021 – Dr. Rendong Yang, head of the Computational Cancer Genomics lab at The Hormel Institute, University of Minnesota published breakthrough research on exitron splicing (EIS) and its role in cancer. Dr. Yang and…
Dr. Mark Juckett named Masonic Cancer Center CTO-CGI Medical Director
April 15, 2021 - Mark Juckett, MD, Professor of Medicine, Division of Hematology, Oncology, and Transplantation (HOT) of the University of Minnesota Medical School, was appointed Medical Director of the Masonic Cancer Center Clinical…
Institute scientist researches new treatment for ovarian cancer
Targeted cancer stem cell treatment could reduce recurrence